Jiangsu EACHY Biopharmaceuticals Co., Ltd.

Eachy Biopharmaceuticals was founded in 2013, focuses on prognostics innovation in the field of cardiovascular disease, inflammation, and metabolic syndrome. It provides the promising medical solution to clients using its proprietary technologies in biomarkers, human resource antibodies and high-throughput screening. Eachy already has 25 patents and established three technology platforms: Chemiluminescence, time-resolved immunofluorescence chromatography, nano gold lateral immunochromatography to manufacture high sensitivity and accuracy products.

Eachy has developed 5 kind of kits to diagnosis , and got CE marker. Controlled by the ISO13485 quality system, Eachy will always provide professional services for customers.